30 Dec 2019 Posted at 17:34h in Uncategorized by carl Share 16 August 2019: Phase II clinical trial for glioblastoma (GBM) approved by the NSW Human Research Ethics Committee (HREC) in Australia 19 December 2019: Phase I clinical trial on solid tumours approved by USA FDA
